https://seychelleshealthnews.com/article/911981428-cytokinetics-announces-new-data-related-to-myqorzo-aficamten-at-esc-heart-failure-2026 Seychelles Health News en PressRelease 2026-05-11T14:06:00+00:00 Cytokinetics Announces New Data Related to MYQORZO® (aficamten) at ESC Heart Failure 2026 https://ml.globenewswire.com/media/5179347f-327c-44f4-9e9c-4e74b9ade881/medium/figure-1-dose-dependent-effects-of-aficamten-compared-with-m.png https://seychelleshealthnews.com/article/911981535-plan-d-action-en-pr-vention-la-coalition-qu-b-coise-pour-la-r-duction-de-la-maladie-salue-le-d-voilement Seychelles Health News en PressRelease 2026-05-11T14:04:51+00:00 Plan d'action en prévention : La Coalition québécoise pour la réduction de la maladie salue le dévoilement https://ml.globenewswire.com/media/d08d28a1-d1c3-4a4a-a82e-6e41f9a9e9dd/small/aspq-1-png.JPG https://seychelleshealthnews.com/article/911981308-national-nurses-week-simple-modern-partners-with-four-hospitals-to-support-nurses Seychelles Health News en PressRelease 2026-05-11T14:00:00+00:00 National Nurses Week: Simple Modern Partners with Four Hospitals to Support Nurses https://ml.globenewswire.com/media/Mzg3Y2ZlMTYtNDA4Ni00YjM1LWFhMGUtNmViMDYwZWFhYzNlLTUwMDE0OTM4Mi0yMDI2LTA1LTExLWVu/tiny/Simple-Modern.png https://seychelleshealthnews.com/article/911981349-110-years-110-stories-110-reasons-to-raise-awareness-for-gbs Seychelles Health News en PressRelease 2026-05-11T14:00:00+00:00 110 Years. 110 Stories. 110 Reasons to Raise Awareness for GBS https://ml.globenewswire.com/media/cd44ffa5-89d9-447b-b8b6-123bab39258b/small/gbs-cidp-logo-png.png https://seychelleshealthnews.com/article/911981391-acoramidis-continues-to-demonstrate-disease-modifying-effects-in-attr-cm-reducing-sttr-variability-and-outpatient-worsening-heart-failure Seychelles Health News en PressRelease 2026-05-11T13:30:00+00:00 Acoramidis Continues to Demonstrate Disease-Modifying Effects in ATTR-CM, Reducing sTTR Variability and Outpatient Worsening Heart Failure https://ml.globenewswire.com/media/2074ba9b-0e5b-41fa-baac-553f1345bb75/small/bridge-bio-black-png.png https://seychelleshealthnews.com/article/911981486-lifeward-to-report-first-quarter-2026-financial-results-on-may-15-2026 Seychelles Health News en PressRelease 2026-05-11T13:25:58+00:00 Lifeward to Report First Quarter 2026 Financial Results on May 15, 2026 https://ml.globenewswire.com/media/9343d7ac-5bc7-4a60-a2c9-a41bf7b5e007/small/lifeward-full-logo-rgb-for-web-01-jpg.jpg https://seychelleshealthnews.com/article/911970095-biodesix-announces-ats-2026-presentations-providing-real-world-clinical-evidence-and-healthcare-system-economic-value-for-nodify-lung-testing Seychelles Health News en PressRelease 2026-05-11T13:17:00+00:00 Biodesix Announces ATS 2026 Presentations Providing Real-World Clinical Evidence and Healthcare System Economic Value for Nodify Lung® Testing Strategy https://ml.globenewswire.com/media/b2fd8e3c-ff04-47d9-938d-93c9c961ccc3/small/bdsx-logo-1200x240-png.png https://seychelleshealthnews.com/article/911970057-ernexa-therapeutics-releases-virtual-investor-kol-connect-segment-highlighting-ovarian-cancer-landscape-and-lead-candidate-erna-101 Seychelles Health News en PressRelease 2026-05-11T13:15:00+00:00 Ernexa Therapeutics Releases Virtual Investor KOL Connect Segment Highlighting Ovarian Cancer Landscape and Lead Candidate ERNA-101 https://ml.globenewswire.com/media/bb12f9ec-b7e7-4d8c-92df-cf27e238c398/small/ernexa-color-png.png https://seychelleshealthnews.com/article/911970069-anaptys-appoints-chris-murphy-as-chief-financial-officer-and-owen-hughes-to-board-of-directors Seychelles Health News en PressRelease 2026-05-11T13:15:00+00:00 Anaptys Appoints Chris Murphy as Chief Financial Officer and Owen Hughes to Board of Directors https://ml.globenewswire.com/media/eb223f66-e7e0-4e0a-94e7-a3f7a06b13ab/small/anaptys-logo-png.png https://seychelleshealthnews.com/article/911970214-work-medical-collaborates-with-novabioplus-to-unlock-biological-data-value-with-ai-advancing-the-biotoken-assetization-model Seychelles Health News en PressRelease 2026-05-11T13:15:00+00:00 WORK Medical Collaborates with Novabioplus to Unlock Biological Data Value with AI, Advancing the “BioToken” Assetization Model https://ml.globenewswire.com/media/7c9dd1a3-c713-4b34-820d-2c5ef0c0e8b7/small/wok-logo-png.png https://seychelleshealthnews.com/article/911970172-longeveron-announces-independent-data-monitoring-committee-positive-review-and-recommendation-to-complete-phase-2b-stem-cell-therapy-clinical-trial-in Seychelles Health News en PressRelease 2026-05-11T13:10:00+00:00 Longeveron Announces Independent Data Monitoring Committee Positive Review and Recommendation to Complete Phase 2b Stem Cell Therapy Clinical Trial in Hypoplastic Left Heart Syndrome (HLHS) https://ml.globenewswire.com/media/e9e96d9c-d6c3-4aec-ba85-36631b520211/medium/nataliya-agafonova.png https://seychelleshealthnews.com/article/911970092-hifi-solves-sub-fertility-consortium-in-asia-pacific-reports-first-major-study-using-hifi-long-read-sequencing-to-investigate-unexplained-subfertility Seychelles Health News en PressRelease 2026-05-11T13:05:00+00:00 HiFi Solves Sub-fertility Consortium in Asia Pacific Reports First Major Study Using HiFi Long-Read Sequencing to Investigate Unexplained Subfertility and Recurrent Pregnancy Loss https://ml.globenewswire.com/media/f408d681-e68c-4113-a7cd-be24486deefc/small/logo-centered-440x386-png.png https://seychelleshealthnews.com/article/911969963-thousands-of-canadians-to-come-together-for-ms-walk-this-may-to-support-the-ms-community Seychelles Health News en PressRelease 2026-05-11T13:00:00+00:00 Thousands of Canadians to Come Together for MS Walk This May to Support the MS Community https://ml.globenewswire.com/media/MzVhZDNkMWUtMDE1Mi00MzE1LThlMzYtNzAwMzFkNDc3NTQ4LTUwMDEyNTMxMy0yMDI2LTA1LTExLWVu/tiny/MS-Canada.png https://seychelleshealthnews.com/article/911969998-sol-sence-launches-new-skin-health-technologies-whspr-and-chromal-m Seychelles Health News en PressRelease 2026-05-11T13:00:00+00:00 Solésence Launches New Skin Health Technologies: WHSPR™ and Chromalüm™ https://ml.globenewswire.com/media/cd3e5e4e-9567-4a86-8f44-900ffeb29d33/small/solesence-fullcolor-300dpi-social-002-1-png.png https://seychelleshealthnews.com/article/911970304-newamsterdam-pharma-to-participate-at-upcoming-investor-conferences-in-may Seychelles Health News en PressRelease 2026-05-11T12:41:05+00:00 NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in May https://ml.globenewswire.com/media/f7b8b881-9461-4712-9965-707ed3bdd573/small/newamsterdam-logo-full-color-final-png.png https://seychelleshealthnews.com/article/911969966-adial-pharmaceuticals-reports-2026-first-quarter-financial-results-and-provides-business-update Seychelles Health News en PressRelease 2026-05-11T12:30:00+00:00 Adial Pharmaceuticals Reports 2026 First Quarter Financial Results and Provides Business Update https://ml.globenewswire.com/media/e6fc09f7-5847-46c8-9294-f51162a7e518/small/adil-logo-png.png https://seychelleshealthnews.com/article/911970037-abeona-therapeutics-announces-activation-of-children-s-hospital-of-philadelphia-as-a-new-qualified-treatment-center-for-zevaskyn Seychelles Health News en PressRelease 2026-05-11T12:30:00+00:00 Abeona Therapeutics® Announces Activation of Children's Hospital of Philadelphia as a New Qualified Treatment Center for ZEVASKYN® https://ml.globenewswire.com/media/f11f9f14-9744-4666-aef3-9771488c41bd/small/thumb-1740-12-silhouette-vertical-full-color-png.png https://seychelleshealthnews.com/article/911970074-disc-medicine-to-participate-in-upcoming-investor-conferences Seychelles Health News en PressRelease 2026-05-11T12:30:00+00:00 Disc Medicine to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/d212c899-9a87-4500-9382-573dfe9f12af/small/disc-logo-horiz-fullcolor-rgb-jpg.jpg https://seychelleshealthnews.com/article/911970076-fibrobiologics-advancing-development-of-a-fibroblast-treatment-for-hantavirus Seychelles Health News en PressRelease 2026-05-11T12:30:00+00:00 FibroBiologics Advancing Development of a Fibroblast Treatment for Hantavirus https://ml.globenewswire.com/media/720fe0fe-52b4-4ccc-a5ad-95d4288f1df2/small/fibrobiologics-logo-2022-jpg.jpg https://seychelleshealthnews.com/article/911970158-the-next-generation-of-the-glp-1-revolution-is-already-underway Seychelles Health News en PressRelease 2026-05-11T12:30:00+00:00 The Next Generation of the GLP-1 Revolution Is Already Underway https://ml.globenewswire.com/media/920a567d-2571-4a09-a6f6-bcc7f1c26bd7/small/biomedwire-full-png.png https://seychelleshealthnews.com/article/911970162-fate-therapeutics-showcases-ft819-clinical-activity-in-sle-without-the-use-of-conditioning-chemotherapy-at-the-2026-asgct-annual-meeting Seychelles Health News en PressRelease 2026-05-11T12:30:00+00:00 Fate Therapeutics Showcases FT819 Clinical Activity in SLE without the use of Conditioning Chemotherapy at the 2026 ASGCT Annual Meeting https://ml.globenewswire.com/media/2acb7cd9-5f5c-42d0-a606-72d085e2fe6e/small/fate-therapeutics-jpg.jpg https://seychelleshealthnews.com/article/911970176-the-future-of-intoxication-detection-may-be-in-your-voice Seychelles Health News en PressRelease 2026-05-11T12:30:00+00:00 The Future of Intoxication Detection May Be in Your Voice https://ml.globenewswire.com/media/920a567d-2571-4a09-a6f6-bcc7f1c26bd7/small/biomedwire-full-png.png https://seychelleshealthnews.com/article/911970184-cns-drug-delivery-breakthroughs-unlock-significant-biotech-market-opportunities Seychelles Health News en PressRelease 2026-05-11T12:30:00+00:00 CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities https://ml.globenewswire.com/media/920a567d-2571-4a09-a6f6-bcc7f1c26bd7/small/biomedwire-full-png.png https://seychelleshealthnews.com/article/911970230-cruise-ship-virus-outbreaks-highlight-massive-emerging-demand-for-tomi-environmental-solutions-steramist-technology Seychelles Health News en PressRelease 2026-05-11T12:30:00+00:00 Cruise Ship Virus Outbreaks Highlight Massive Emerging Demand for TOMI Environmental Solutions’ SteraMist Technology https://ml.globenewswire.com/media/f8c7c513-0121-4507-84b7-3680626d9cf3/small/tomi-jpg.jpg https://seychelleshealthnews.com/article/911970268-humanitarian-organization-care-marks-80th-anniversary-of-the-original-care-package Seychelles Health News en PressRelease 2026-05-11T12:23:03+00:00 Humanitarian organization CARE marks 80th anniversary of the original CARE PACKAGE® https://ml.globenewswire.com/media/OTUxMDFiMjEtNjgzNC00Njc4LTgxOGYtZWEzZWU3ZjdiYjFiLTEzMDEwNjQtMjAyNi0wNS0xMS1lbg==/tiny/CARE.png https://seychelleshealthnews.com/article/911959972-sarm1-sir2501-fda-cipn Seychelles Health News en PressRelease 2026-05-11T12:13:40+00:00 维泰瑞隆SARM1抑制剂SIR2501获FDA快速通道资格，用于治疗化疗所致的周围神经病变（CIPN） https://ml.globenewswire.com/media/324eaac0-0f76-4b80-8917-0c56a174ae30/small/sironax-logo-768x768-png.png https://seychelleshealthnews.com/article/911959975-sarm1-sir2501-fda-cipn Seychelles Health News en PressRelease 2026-05-11T12:13:40+00:00 維泰瑞隆SARM1抑制劑SIR2501獲FDA快速通道資格，用於治療化療所致的周圍神經病變（CIPN） https://ml.globenewswire.com/media/324eaac0-0f76-4b80-8917-0c56a174ae30/small/sironax-logo-768x768-png.png https://seychelleshealthnews.com/article/911959487-cellectar-biosciences-to-report-first-quarter-financial-results-and-host-a-conference-call-on-thursday-may-14-2026 Seychelles Health News en PressRelease 2026-05-11T12:05:00+00:00 Cellectar Biosciences to Report First Quarter Financial Results and Host a Conference Call on Thursday, May 14, 2026 https://ml.globenewswire.com/media/980abc5d-826f-4ac3-ad81-f07d69b34af6/small/cellectar-logo-1-jpg.jpg https://seychelleshealthnews.com/article/911959399-reunion-neuroscience-to-present-full-data-from-reconnect-phase-2-clinical-trial-at-upcoming-ascp-and-apa-annual-meetings Seychelles Health News en PressRelease 2026-05-11T12:01:00+00:00 Reunion Neuroscience to Present Full Data from RECONNECT Phase 2 Clinical Trial at Upcoming ASCP and APA Annual Meetings https://ml.globenewswire.com/media/2502ac40-fe76-4563-9529-2a086eb87a7e/small/reunion-neuroscience-inc-logo-jpg.JPG https://seychelleshealthnews.com/article/911959366-proqr-announces-multiple-upcoming-scientific-conference-presentations-highlighting-the-breadth-of-its-axiomer-rna-editing-platform Seychelles Health News en PressRelease 2026-05-11T12:00:00+00:00 ProQR Announces Multiple Upcoming Scientific Conference Presentations Highlighting the Breadth of its Axiomer™ RNA Editing Platform https://ml-eu.globenewswire.com/media/f5ae7794-bff7-44dc-8709-0e9c3a9eac77/small/logo-proqr-150x150-png.png https://seychelleshealthnews.com/article/911959386-cptx-appoints-edward-rebar-as-chief-scientific-officer Seychelles Health News en PressRelease 2026-05-11T12:00:00+00:00 CPTx appoints Edward Rebar as Chief Scientific Officer https://ml-eu.globenewswire.com/media/b64c4107-603f-414a-89ef-cea176de3641/medium/edward-rebar.jpg https://seychelleshealthnews.com/article/911959392-galectin-therapeutics-announces-publication-of-navigate-phase-2b-trial-results-for-belapectin-in-the-journal-of-hepatology Seychelles Health News en PressRelease 2026-05-11T12:00:00+00:00 Galectin Therapeutics Announces Publication of NAVIGATE Phase 2b Trial Results for Belapectin in the Journal of Hepatology https://ml.globenewswire.com/media/dd593f5d-61a4-4e6b-87d3-b9deb9f5d33f/small/galectin-jpg.jpg https://seychelleshealthnews.com/article/911959407-agc-biologics-joins-orphan-therapeutics-accelerator-s-clinical-development-network-as-a-manufacturing-partner-to-advance-cell-and-gene-therapies-for Seychelles Health News en PressRelease 2026-05-11T12:00:00+00:00 AGC Biologics Joins Orphan Therapeutics Accelerator’s Clinical Development Network as a Manufacturing Partner to Advance Cell and Gene Therapies for Ultra-Rare Diseases https://ml.globenewswire.com/media/a770575b-6ec9-43d7-8a68-60aaf38661ee/medium/agc-biologics-joins-orphan-therapeutics-accelerators-clinica.jpg https://seychelleshealthnews.com/article/911959498-jabez-biosciences-presents-first-in-human-pharmacokinetic-and-pharmacodynamic-data-for-jbz-001-at-aacr-annual-meeting-2026 Seychelles Health News en PressRelease 2026-05-11T12:00:00+00:00 Jabez Biosciences Presents First-in-Human Pharmacokinetic and Pharmacodynamic Data for JBZ-001 at AACR Annual Meeting 2026 https://ml.globenewswire.com/media/MDlhZWI1ZGYtNjc5OC00ZjY0LWEzM2EtMzFhMTk0OTYyMDE1LTEzMTU5OTAtMjAyNi0wNS0xMS1lbg==/tiny/Jabez-Biosciences-Inc-.png https://seychelleshealthnews.com/article/911959529-apyx-medical-corporation-receives-expanded-fda-510-k-clearance-adding-power-liposuction-capability-to-ayon-body-contouring-system Seychelles Health News en PressRelease 2026-05-11T12:00:00+00:00 Apyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System™ https://ml.globenewswire.com/media/aa0687d3-ab28-4615-b1e7-ef6c6e2a5541/small/apyx-medical-logo-jpg.jpg https://seychelleshealthnews.com/article/911959672-exagen-inc-reports-first-quarter-2026-results Seychelles Health News en PressRelease 2026-05-11T12:00:00+00:00 Exagen Inc. Reports First Quarter 2026 Results https://ml.globenewswire.com/media/56891beb-9424-4bd8-98ed-ade5f6c1f4c6/small/exagen-logo-288-x-103-px-tranparent-background-png.png https://seychelleshealthnews.com/article/911959789-first-participant-dosed-in-askbio-phase-1-phase-2-gene-therapy-trial-of-ab-1009-for-late-onset-pompe-disease-lopd Seychelles Health News en PressRelease 2026-05-11T12:00:00+00:00 First Participant Dosed in AskBio Phase 1/Phase 2 Gene Therapy Trial of AB-1009 for Late-Onset Pompe Disease (LOPD) https://ml.globenewswire.com/media/YTc1MDFlYzYtZTEyOC00YmJmLWI2ODktNTMyNTgxNDA1ODgzLTEyODY3MTItMjAyNi0wNS0xMS1lbg==/tiny/Asklepios-BioPharmaceutical-In.png https://seychelleshealthnews.com/article/911959850-assembly-biosciences-to-present-at-the-bofa-securities-2026-global-health-care-conference Seychelles Health News en PressRelease 2026-05-11T12:00:00+00:00 Assembly Biosciences to Present at the BofA Securities 2026 Global Health Care Conference https://ml.globenewswire.com/media/33089548-b62b-412d-9343-ae38d8b720c6/small/assemblybio-logo-rgb-png.png https://seychelleshealthnews.com/article/911959868-sironax-s-sarm1-inhibitor-sir2501-granted-fda-fast-track-designation-in-chemotherapy-induced-peripheral-neuropathy-cipn Seychelles Health News en PressRelease 2026-05-11T12:00:00+00:00 Sironax’s SARM1 Inhibitor SIR2501 Granted FDA Fast Track Designation in Chemotherapy-induced Peripheral Neuropathy (CIPN) https://ml.globenewswire.com/media/324eaac0-0f76-4b80-8917-0c56a174ae30/small/sironax-logo-768x768-png.png https://seychelleshealthnews.com/article/911959862-clearmind-medicine-announces-inside-meai-webinar-featuring-new-insights-from-cmnd-100-psychedelic-clinical-trial Seychelles Health News en PressRelease 2026-05-11T11:55:00+00:00 Clearmind Medicine Announces “Inside MEAI” Webinar Featuring New Insights from CMND-100 Psychedelic Clinical Trial https://ml.globenewswire.com/media/bd17cbf4-8124-4f86-8a4c-1fafbb6785af/small/logo-jpg.jpg https://seychelleshealthnews.com/article/911959781-inspira-technologies-ceo-issues-letter-to-shareholders-on-strategic-direction-and-value-creation-plan Seychelles Health News en PressRelease 2026-05-11T11:31:00+00:00 Inspira Technologies CEO Issues Letter to Shareholders on Strategic Direction and Value Creation Plan https://ml.globenewswire.com/media/6a4eabfe-c9ec-40d1-87fc-6f0d8e6e408c/small/screenshot-2025-04-02-at-19-21-06-png.png https://seychelleshealthnews.com/article/911959489-intellia-therapeutics-announces-first-quarter-2026-financial-results-and-business-updates Seychelles Health News en PressRelease 2026-05-11T11:30:00+00:00 Intellia Therapeutics Announces First Quarter 2026 Financial Results and Business Updates https://ml.globenewswire.com/media/9b6b17bb-c8a4-4009-b5f8-8cadb4d2296a/small/intellia-jpg.jpg https://seychelleshealthnews.com/article/911959534-optimizerx-launches-programmatic-access-to-authenticated-ehr-advertising-at-scale Seychelles Health News en PressRelease 2026-05-11T11:30:00+00:00 OptimizeRx Launches Programmatic Access to Authenticated EHR Advertising at Scale https://ml.globenewswire.com/media/a0504bf7-72fc-4cd4-8489-a207313dbabd/small/oprx-logo-jpg.jpg https://seychelleshealthnews.com/article/911959637-cronos-group-reports-2026-first-quarter-results Seychelles Health News en PressRelease 2026-05-11T11:30:00+00:00 Cronos Group Reports 2026 First Quarter Results https://ml.globenewswire.com/media/68e2d88b-b8e0-404a-995d-415a33773982/small/cronos-wm-black-logo-2-2-jpg.jpg https://seychelleshealthnews.com/article/911959689-dyne-therapeutics-reports-first-quarter-2026-financial-results-and-recent-business-highlights Seychelles Health News en PressRelease 2026-05-11T11:30:00+00:00 Dyne Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Highlights https://ml.globenewswire.com/media/2aa597a4-9b5c-4f0c-9ada-c5e06fa7d4de/small/dynelogo-r-final-full-color-rgb-jpg.jpg https://seychelleshealthnews.com/article/911959696-roe-dental-laboratory-becomes-first-u-s-lab-to-deploy-an-extensive-fleet-of-3d-systems-jetted-denture-printing-systems-across-multiple-sites Seychelles Health News en PressRelease 2026-05-11T11:30:00+00:00 ROE Dental Laboratory Becomes First U.S. Lab to Deploy an Extensive Fleet of 3D Systems Jetted-Denture Printing Systems Across Multiple Sites https://ml.globenewswire.com/media/c1fe14d5-b586-4dca-a30b-fdfd171ae76f/small/3d-jpg.jpg https://seychelleshealthnews.com/article/911959841-bicara-therapeutics-reports-first-quarter-2026-financial-results-and-provides-business-update Seychelles Health News en PressRelease 2026-05-11T11:30:00+00:00 Bicara Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/fdf5e06f-0748-428a-8f90-b0a1c6f7bdf3/small/bicara-logo-struck-png.png https://seychelleshealthnews.com/article/911959662-alterity-therapeutics-announces-publication-demonstrating-the-utility-of-quantitative-mri-as-a-biomarker-for-multiple-system-atrophy Seychelles Health News en PressRelease 2026-05-11T11:25:00+00:00 Alterity Therapeutics Announces Publication Demonstrating the Utility of Quantitative MRI as a Biomarker for Multiple System Atrophy https://ml.globenewswire.com/media/0771a9a2-2ac1-4a63-9767-a2b1df74af27/small/alterity-png.png https://seychelleshealthnews.com/article/911949613-kraig-biocraft-laboratories-commissions-new-production-rearing-center-to-support-accelerating-spider-silk-scale-up Seychelles Health News en PressRelease 2026-05-11T11:05:00+00:00 Kraig Biocraft Laboratories Commissions New Production Rearing Center to Support Accelerating Spider Silk Scale-Up https://ml.globenewswire.com/media/3cf5ab91-0822-460b-bb13-17447941c84a/small/kblb-logo-jpg.jpg https://seychelleshealthnews.com/article/911949538-invivyd-and-collaborators-author-new-manuscript-evaluating-early-tolerability-of-covid-monoclonal-antibody-and-comparing-results-to-covid-vaccination Seychelles Health News en PressRelease 2026-05-11T11:01:00+00:00 Invivyd and Collaborators Author New Manuscript Evaluating Early Tolerability of COVID Monoclonal Antibody and Comparing Results to COVID Vaccination https://ml.globenewswire.com/media/7bf12f50-1073-4ce7-81ac-89426c07add3/small/untitled-design-2-png.png https://seychelleshealthnews.com/article/911949313-4basebio-launches-enzymatic-ssdna-platform Seychelles Health News en PressRelease 2026-05-11T11:00:00+00:00 4basebio Launches Enzymatic ssDNA Platform https://ml-eu.globenewswire.com/media/b4cdfb28-5792-4f0a-b80f-b960556fe025/small/4basebio-logo-1-png.png https://seychelleshealthnews.com/article/911949353-apogee-therapeutics-provides-pipeline-progress-and-reports-first-quarter-2026-financial-results Seychelles Health News en PressRelease 2026-05-11T11:00:00+00:00 Apogee Therapeutics Provides Pipeline Progress and Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/c7ab4c17-2e41-4560-b2a2-70d0c23c8c8b/small/apogeelogo-png.png https://seychelleshealthnews.com/article/911949410-fractyl-health-authorized-to-initiate-first-in-human-trial-of-rjva-001-in-the-netherlands-first-gene-therapy-candidate-to-enter-clinical-development Seychelles Health News en PressRelease 2026-05-11T11:00:00+00:00 Fractyl Health Authorized to Initiate First-in-Human Trial of RJVA-001 in the Netherlands: First Gene Therapy Candidate to Enter Clinical Development for Type 2 Diabetes https://ml.globenewswire.com/media/3a379315-9c07-4655-883e-7e7f26c67778/small/fractyl-logo-png.png https://seychelleshealthnews.com/article/911949413-sagimet-biosciences-to-present-mechanism-of-action-data-for-its-fasn-inhibitors-at-the-society-for-investigative-dermatology-in-chicago Seychelles Health News en PressRelease 2026-05-11T11:00:00+00:00 Sagimet Biosciences to Present Mechanism of Action Data for its FASN Inhibitors at the Society for Investigative Dermatology in Chicago https://ml.globenewswire.com/media/e944daed-3f71-402b-bb23-82149e5c0d26/small/sagimet-logo-for-light-bg-fin-png.png https://seychelleshealthnews.com/article/911949451-actuate-therapeutics-announces-fda-clearance-of-ind-for-oral-elraglusib-and-strategic-initiatives-to-advance-the-elraglusib-development-program Seychelles Health News en PressRelease 2026-05-11T11:00:00+00:00 Actuate Therapeutics Announces FDA Clearance of IND for Oral Elraglusib and Strategic Initiatives to Advance the Elraglusib Development Program https://ml.globenewswire.com/media/f65ca94c-eff8-4376-ac67-ded1b03b3bcc/small/actuatetx-logo-color300-jpg.jpg https://seychelleshealthnews.com/article/911949531-alpha-tau-announces-groundbreaking-interim-results-from-its-u-s-alpha-dart-recurrent-glioblastoma-trial-with-100-local-disease-control-67 Seychelles Health News en PressRelease 2026-05-11T11:00:00+00:00 Alpha Tau Announces Groundbreaking Interim Results from its U.S. Alpha DaRT® Recurrent Glioblastoma Trial, with 100% Local Disease Control, 67% Complete Response Rate, and Favorable Safety Profile Observed - Conference Call Scheduled for 8:30am ET https://ml.globenewswire.com/media/a9de6f03-a487-4934-98e9-d25cdb4c8bed/small/atm-logo-jpg.jpg https://seychelleshealthnews.com/article/911949545-dark-horse-consulting-group-and-kuntuo-announce-memorandum-of-understanding-providing-cell-and-gene-therapy-developers-with-an-accelerated-path-to Seychelles Health News en PressRelease 2026-05-11T11:00:00+00:00 Dark Horse Consulting Group and KunTuo Announce Memorandum of Understanding Providing Cell and Gene Therapy Developers with an Accelerated Path to Clinical Development in China https://ml.globenewswire.com/media/b96e7c60-949b-4a7d-9d4e-8d9766cf8c87/small/2025-dhcg-logo-color-jpg.jpg https://seychelleshealthnews.com/article/911949571-rezolute-to-participate-in-upcoming-investor-conferences Seychelles Health News en PressRelease 2026-05-11T11:00:00+00:00 Rezolute to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/bbe03de3-6870-4230-b875-d8965a3d1b97/small/rezolute-jpg.jpg https://seychelleshealthnews.com/article/911949580-mbx-biosciences-provides-obesity-portfolio-update-including-initial-phase-1-data-for-mbx-4291-supporting-potential-for-once-monthly-dosing Seychelles Health News en PressRelease 2026-05-11T11:00:00+00:00 MBX Biosciences Provides Obesity Portfolio Update Including Initial Phase 1 Data for MBX 4291 Supporting Potential for Once-Monthly Dosing https://ml.globenewswire.com/media/5499b327-bce0-4a3f-96a7-04a38b68a99f/small/mbx-logos-final-full-jpg.jpg https://seychelleshealthnews.com/article/911949598-lexeo-therapeutics-reports-first-quarter-2026-financial-results-and-operational-highlights Seychelles Health News en PressRelease 2026-05-11T11:00:00+00:00 Lexeo Therapeutics Reports First Quarter 2026 Financial Results and Operational Highlights https://ml.globenewswire.com/media/85c275df-e665-426f-a3bc-4a839a0b34d3/small/lexeo-logo-png.png https://seychelleshealthnews.com/article/911949611-gain-therapeutics-reports-financial-results-for-first-quarter-2026-and-provides-corporate-update Seychelles Health News en PressRelease 2026-05-11T11:00:00+00:00 Gain Therapeutics Reports Financial Results for First Quarter 2026 and Provides Corporate Update https://ml.globenewswire.com/media/b08fa984-9f20-4aa1-a174-b9f6165d50fa/small/gainlogo-png.png https://seychelleshealthnews.com/article/911949616-erasca-announces-clinical-trial-collaboration-and-supply-agreement-with-merck-to-evaluate-eras-0015-in-combination-with-keytruda-pembrolizumab Seychelles Health News en PressRelease 2026-05-11T11:00:00+00:00 Erasca Announces Clinical Trial Collaboration and Supply Agreement with Merck to Evaluate ERAS-0015 in Combination with KEYTRUDA® (Pembrolizumab) https://ml.globenewswire.com/media/266fe248-70d0-4904-b12e-e0d5a990f816/small/erascatm-logo-png.png https://seychelleshealthnews.com/article/911949619-conavi-medical-corp-announces-proposed-public-offering-of-common-shares-and-pre-funded-warrants Seychelles Health News en PressRelease 2026-05-11T11:00:00+00:00 Conavi Medical Corp. Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants https://ml.globenewswire.com/media/4a28f1c0-f99d-4940-b2a7-201ab98cdaff/small/conavi-jpg.jpg https://seychelleshealthnews.com/article/911949660-new-data-shows-5x-growth-in-medical-crowdfunding-across-europe Seychelles Health News en PressRelease 2026-05-11T10:39:06+00:00 New data shows 5x growth in medical crowdfunding across Europe https://ml.globenewswire.com/media/5064bb8d-e4da-4bb6-9c7f-7e699af0823c/medium/reimbursement-gap-in-medical-insurance-in-eu.png https://seychelleshealthnews.com/article/911949541-certara-reports-first-quarter-2026-financial-results Seychelles Health News en PressRelease 2026-05-11T10:25:00+00:00 Certara Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/6da79355-1c12-4676-93c4-f765b2948060/small/rgbcertara-logo-large-blackhigh-res-png.png https://seychelleshealthnews.com/article/911930501-alvotech-announces-completion-of-fda-surveillance-inspection-at-reykjavik-facility Seychelles Health News en PressRelease 2026-05-11T08:30:00+00:00 Alvotech Announces Completion of FDA Surveillance Inspection at Reykjavik Facility https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg https://seychelleshealthnews.com/article/911922200-ena-respiratory-successfully-completes-first-part-of-phase-ii-study-of-inna-051-nasal-spray-designed-to-protect-against-symptomatic-viral-respiratory Seychelles Health News en PressRelease 2026-05-11T08:00:00+00:00 ENA Respiratory Successfully Completes First Part of Phase II Study of INNA-051 Nasal Spray Designed to Protect Against Symptomatic Viral Respiratory Infections https://ml-eu.globenewswire.com/media/84159208-c519-49a5-86c6-56151e3ab92b/small/ena-png.png https://seychelleshealthnews.com/article/911922246-anaveon-announces-presentation-of-positive-anv600-clinical-data-at-asco-2026-and-actively-seeks-partners-for-its-legacy-oncology-portfolio Seychelles Health News en PressRelease 2026-05-11T08:00:00+00:00 Anaveon Announces Presentation of Positive ANV600 Clinical Data at ASCO 2026 and Actively Seeks Partners for its Legacy Oncology Portfolio https://ml.globenewswire.com/media/376f71da-1a19-4a9a-bb0a-5d12feb63780/small/logo-anaveon-jpg.jpg https://seychelleshealthnews.com/article/911914256-positive-results-from-pulsesight-s-phase-i-clinical-trial-of-pst-611-in-dry-amd-geographic-atrophy-presented-at-arvo-2026 Seychelles Health News en PressRelease 2026-05-11T07:00:00+00:00 Positive Results from PulseSight’s Phase I Clinical Trial of PST-611 in Dry AMD/Geographic Atrophy Presented at ARVO 2026 https://ml-eu.globenewswire.com/media/9f8ee53c-2465-4c3c-870e-4077c6a39edb/small/pulsesight-therapeutics-logo-horizontal-full-gradient-mark-0.png https://seychelleshealthnews.com/article/911914260-nxera-pharma-announces-progress-of-out-licensing-of-gpcr-targeted-program-and-participation-in-series-a-financing Seychelles Health News en PressRelease 2026-05-11T06:34:51+00:00 Nxera Pharma Announces Progress of Out-Licensing of GPCR-targeted Program and Participation in Series A Financing https://ml-eu.globenewswire.com/media/5cc74d52-c86f-4e21-8684-3496281fee15/small/nxera-master-logo-rgb-black-1-png.png https://seychelleshealthnews.com/article/911900174-pulsetto-vagus-nerve-stimulator-2026-claims-features-and-feedback-under-investigation Seychelles Health News en PressRelease 2026-05-11T04:51:36+00:00 Pulsetto Vagus Nerve Stimulator 2026 Claims, Features, and Feedback Under Investigation https://ml.globenewswire.com/Resource/Download/a32ce3a3-1115-4d13-a47c-0516fa94b0b7/whatsapp-image-2026-05-11-at-9-56-52-am.jpeg https://seychelleshealthnews.com/article/911844395-radnet-reports-record-first-quarter-financial-results-and-revises-upwards-2026-imaging-center-financial-guidance-ranges-for-revenue-adjusted-ebitda Seychelles Health News en PressRelease 2026-05-10T20:05:00+00:00 RadNet Reports Record First Quarter Financial Results and Revises Upwards 2026 Imaging Center Financial Guidance Ranges for Revenue, Adjusted EBITDA and Free Cash Flow https://ml.globenewswire.com/media/0df5f357-aa64-4998-a83f-f1561aef685d/small/logo-radnet-profile2-jpg.jpg https://seychelleshealthnews.com/article/911806251-healthy-moms-healthy-babies-america-launches-national-campaign-to-cut-u-s-maternal-mortality-in-half-within-five-years Seychelles Health News en PressRelease 2026-05-10T15:00:00+00:00 Healthy Moms, Healthy Babies America Launches National Campaign to Cut U.S. Maternal Mortality in Half Within Five Years https://ml.globenewswire.com/media/ZDAzNWUwNTYtNjI5ZC00YWZlLWI0ZTctYWVkYzBiYmNlZTQ4LTUwMDE2MjMzOC0yMDI2LTA1LTEwLWVu/tiny/Healthy-Moms-Healthy-Babies-Am.png https://seychelleshealthnews.com/article/911793196-moonlake-immunotherapeutics-announces-positive-outcome-from-its-final-pre-bla-meeting-with-the-u-s-fda-and-reports-first-quarter-2026-financial Seychelles Health News en PressRelease 2026-05-10T13:00:00+00:00 MoonLake Immunotherapeutics Announces Positive Outcome from its Final Pre-BLA Meeting with the U.S. FDA and Reports First Quarter 2026 Financial Results https://ml-eu.globenewswire.com/media/f894fe8c-bb73-4375-a7de-30c9195f573a/small/moonlake-logo-png.png https://seychelleshealthnews.com/article/911770267-whiteswell-announces-primary-clinical-trial-results-simultaneously-at-heart-failure-2026-congress-and-in-european-journal-of-heart-failure-related-to Seychelles Health News en PressRelease 2026-05-10T09:09:00+00:00 WhiteSwell Announces Primary Clinical Trial Results Simultaneously at Heart Failure 2026 Congress and in European Journal of Heart Failure related to the DELTA-HF Study in Acute Decompensated Heart Failure https://ml.globenewswire.com/media/f735fa38-d2f5-476c-8e2b-e73cfd79e08e/small/whiteswell-logo-002-png.png https://seychelleshealthnews.com/article/911720880-a-pint-for-kim-blood-drive-breaks-illinois-record-for-the-seventh-year-in-a-row-with-over-650-donations-in-one-day Seychelles Health News en PressRelease 2026-05-10T00:57:12+00:00 A Pint for Kim Blood Drive Breaks Illinois Record for the Seventh Year in a Row with over 650 Donations in One Day https://ml.globenewswire.com/media/5cbbb955-4170-4c7b-8641-17d04c4e4327/medium/a-pint-for-kim-blood-drive-breaks-illinois-record-for-sevent.jpeg